Bogdanov, P.; Simó-Servat, O.; Sampedro, J.; Solà -Adell, C.; Garcia-RamÃrez, M.; Ramos, H.; Guerrero, M.; Suñé-Negre, J.M.; Ticó, J.R.; Montoro, B.;
et al. Topical Administration of Bosentan Prevents Retinal Neurodegeneration in Experimental Diabetes. Int. J. Mol. Sci. 2018, 19, 3578.
https://doi.org/10.3390/ijms19113578
AMA Style
Bogdanov P, Simó-Servat O, Sampedro J, Solà -Adell C, Garcia-RamÃrez M, Ramos H, Guerrero M, Suñé-Negre JM, Ticó JR, Montoro B,
et al. Topical Administration of Bosentan Prevents Retinal Neurodegeneration in Experimental Diabetes. International Journal of Molecular Sciences. 2018; 19(11):3578.
https://doi.org/10.3390/ijms19113578
Chicago/Turabian Style
Bogdanov, Patricia, Olga Simó-Servat, Joel Sampedro, Cristina Solà -Adell, Marta Garcia-RamÃrez, Hugo Ramos, Marta Guerrero, Josep Maria Suñé-Negre, Josep Ramon Ticó, Bruno Montoro,
and et al. 2018. "Topical Administration of Bosentan Prevents Retinal Neurodegeneration in Experimental Diabetes" International Journal of Molecular Sciences 19, no. 11: 3578.
https://doi.org/10.3390/ijms19113578
APA Style
Bogdanov, P., Simó-Servat, O., Sampedro, J., Solà -Adell, C., Garcia-RamÃrez, M., Ramos, H., Guerrero, M., Suñé-Negre, J. M., Ticó, J. R., Montoro, B., Durán, V., Arias, L., Hernández, C., & Simó, R.
(2018). Topical Administration of Bosentan Prevents Retinal Neurodegeneration in Experimental Diabetes. International Journal of Molecular Sciences, 19(11), 3578.
https://doi.org/10.3390/ijms19113578